The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDDDD.L Share News (DDDD)

  • There is currently no data for DDDD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EXECUTIVE CHANGE SUMMARY: Primorus Adds Three Directors To Board

Wed, 23rd Sep 2020 19:22

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Wednesday and not separately reported by Alliance News:

----------

Primorus Investments PLC - investment firm focussed on natural resources sector - Appoints Rupert Labrum, Hedley Clark and Matthew Beardmore as directors, subject to due diligence checks, following request from unnamed investor who initially sought to requisition general meeting. Donald Strang to step down when new additions join board but Executive Chair Jeremy Taylor-Firth and Executive Director Alastair Clayton to remain. Primorus notes that notice to requisition general meeting has been withdrawn.

----------

Templeton Emerging Markets IT PLC - emerging markets investor - Adds Medha Samant to board as non-executive director from October 1. Spent about 10 years as investment director for Asian equities at Fidelity International.

----------

Asimilar Group PLC - technology-focused investor - Mark Horrocks joins immediately as non-executive director. "He has worked as a research analyst and fund manager for a FTSE100 insurance group," Asimilar notes. Donald Stewart to step down from board at the conclusion of company annual general meeting.

----------

BB Healthcare Trust PLC - healthcare-focused investor - Appoints Toby Young as non-executive director immediately. "Professor Young is a practicing frontline NHS consultant urological surgeon, director of medical Innovation at Anglia Ruskin University, president of the Institute of Decontamination Sciences, and national clinical director for Innovation for the NHS," BB Healthcare said.

----------

4d Pharma PLC - drug developer - Adds Katrin Rupalla to board as non-executive director with immediate effect. Chief Executive Officer Duncan Peyton said: "We are delighted to be able to attract someone of Katrin's calibre to our board of directors. Her vast experience guiding novel therapies through the clinic will be invaluable as we progress our pipeline of novel live biotherapeutics into and through the clinic."

----------

Hurricane Energy PLC - Goldaming, England-based oil exploration company - Non-executive Director Alan Parsley retired with effect Wednesday. Leonard Tao also steps down as alternate.

----------

Base Resources Ltd - Australia-based mineral sands producer and developer - Appoints Janine Herzig to board as non-executive director from October 12. "Ms Herzig has 30 years' experience in the resources sector, encompassing executive management, consulting, technical and production roles, across all commodities including industrial minerals," Base said. Sam Willis to step down as a non-executive director from November 20.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
8 Feb 2021 08:54

4D Pharma, Merck And Pfizer Ink Trial Collaboration For Carcinoma Drug

4D Pharma, Merck And Pfizer Ink Trial Collaboration For Carcinoma Drug

Read more
3 Feb 2021 11:19

4D Pharma makes progress with MRx0518 development programme

(Sharecast News) - Biotherapeutic pharmaceutical company 4D Pharma announced progress on activities in its development programme for its lead immuno-oncology single strain 'live biotherapeutic' candidate MRx0518 on Wednesday.

Read more
3 Feb 2021 10:50

SMALL-CAP WINNERS & LOSERS: Dr Martens Puts Best Foot Forward

SMALL-CAP WINNERS & LOSERS: Dr Martens Puts Best Foot Forward

Read more
3 Feb 2021 09:01

4D Pharma Says MRx0518 Part B Study Enrolment Continues To Progress

4D Pharma Says MRx0518 Part B Study Enrolment Continues To Progress

Read more
18 Dec 2020 10:13

4D Pharma Joins Landmark Study For Parkinson's Treatment Development

4D Pharma Joins Landmark Study For Parkinson's Treatment Development

Read more
26 Nov 2020 10:53

4D Pharma Files US Registration Statement For ADR Programme

4D Pharma Files US Registration Statement For ADR Programme

Read more
9 Nov 2020 17:28

IN BRIEF: 4d Pharma Reports Positive Data From Ongoing MRx051 Trials

IN BRIEF: 4d Pharma Reports Positive Data From Ongoing MRx051 Trials

Read more
22 Oct 2020 15:42

IN BRIEF: 4D Pharma Proposes Merger With Longevity Acquisition

IN BRIEF: 4D Pharma Proposes Merger With Longevity Acquisition

Read more
22 Oct 2020 11:06

UK WINNERS & LOSERS SUMMARY: Shaftesbury Down 13% Amid Fundraise Plans

UK WINNERS & LOSERS SUMMARY: Shaftesbury Down 13% Amid Fundraise Plans

Read more
7 Oct 2020 11:25

4D Pharma Reports Positive Results From Bowel Syndrome Treatment Trial

4D Pharma Reports Positive Results From Bowel Syndrome Treatment Trial

Read more
30 Sep 2020 12:04

IN BRIEF: 4D Pharma Interim Loss Widens On R&D Costs Increase

IN BRIEF: 4D Pharma Interim Loss Widens On R&D Costs Increase

Read more
26 Aug 2020 10:40

UK WINNERS & LOSERS SUMMARY: Provident Financial Up On Better Outlook

UK WINNERS & LOSERS SUMMARY: Provident Financial Up On Better Outlook

Read more
26 Aug 2020 09:41

4D Pharma Says Results In MRx0518, Keytruda Cancer Trial "Encouraging"

4D Pharma Says Results In MRx0518, Keytruda Cancer Trial "Encouraging"

Read more
13 Jul 2020 18:25

UK TRADING UPDATE SUMMARY: Mineral & Financial Invests In Ideon Tech

UK TRADING UPDATE SUMMARY: Mineral & Financial Invests In Ideon Tech

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.